| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $8.86B | $8.76B | $8.36B |
| YoY Revenue Growth % | +1.1% | +4.7% | — |
| Gross Profit | $2.55B | $2.53B | — |
| Gross Margin % | 28.8% | 28.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $811.8M | $831.8M | $593.5M |
| Operating Margin % | 9.2% | 9.5% | 7.1% |
| Net Income (GAAP) | $688.0M | $704.9M | $503.0M |
| EBITDA (Normalized) | $947.0M | $998.8M | $894.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $881.4M | $938.8M | $826.0M |
| Capital Expenditures (CapEx) | $169.0M | $208.8M | $376.4M |
| Free Cash Flow (FCF) | $712.4M | $730.0M | $449.6M |
| FCF Margin % | 8.0% | 8.3% | 5.4% |
| Return on Invested Capital (ROIC %) | 15.6% | 16.6% | 7.7% |
| Cash & Short-Term Equivalents | $202.8M | $329.1M | — |
| Total Debt (Short + Long Term) | $2.06B | $1.97B | $2.35B |
| Total Stockholders' Equity | $2.24B | $2.31B | $4.82B |